Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Legality  



1.1  United States of America  





1.2  Finland  





1.3  Germany  





1.4  China  





1.5  Others  







2 Mass overdoses due to adulterated K2  





3 See also  





4 References  














AB-FUBINACA






Српски / srpski
Srpskohrvatski / српскохрватски
Suomi
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


AB-FUBINACA
Legal status
Legal status
  • CA: Schedule II
  • DE: Anlage II (Authorized trade only, not prescriptible)
  • UK: Class B
  • US: Schedule I
  • UN: Psychotropic Schedule II
  • Illegal in China
  • Identifiers
    • N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide

    CAS Number
    PubChem CID
    ChemSpider
    UNII
    KEGG
    CompTox Dashboard (EPA)
    Chemical and physical data
    FormulaC20H21FN4O2
    Molar mass368.412 g·mol−1
    3D model (JSmol)
    • CC(C)[C@H](NC(=O)c1nn(Cc2ccc(F)cc2)c3ccccc13)C(N)=O

    • InChI=1S/C20H21FN4O2/c1-12(2)17(19(22)26)23-20(27)18-15-5-3-4-6-16(15)25(24-18)11-13-7-9-14(21)10-8-13/h3-10,12,17H,11H2,1-2H3,(H2,22,26)(H,23,27)/t17-/m0/s1

    • Key:AKOOIMKXADOPDA-KRWDZBQOSA-N

    AB-FUBINACA (AMB-FUBINACA[2]) is a psychoactive drug that acts as a potent agonist for the cannabinoid receptors, with Ki values of 0.9 nM at CB1 and 23.2 nM at CB2 and EC50 values of 1.8 nM at CB1 and 3.2 nM at CB2.[3][4][5] It was originally developed by Pfizer in 2009 as an analgesic medication[6] but was never pursued for human use. In 2012, it was discovered as an ingredient in synthetic cannabinoid blends in Japan,[7] along with a related compound AB-PINACA, which had not previously been reported.

    Its use has been linked to hospitalizations and deaths.[8][9]

    Legality[edit]

    United States of America[edit]

    It was designated as a Schedule I controlled substance in the United States in January 2014.[10]

    Finland[edit]

    In Finland AB-FUBINACA is scheduled in government decree on psychoactive substances banned from the consumer market as of 19 October 2017.[11]

    Germany[edit]

    It is an Anlage II controlled substance in Germany as of November 2014.[12]

    China[edit]

    Since October 2015 AB-FUBINACA is a controlled substance in China.[13]

    Others[edit]

    In December 2019, the UNODC announced scheduling recommendations placing AB-FUBINACA as a controlled research chemical into Schedule II.[14] 101789

    Mass overdoses due to adulterated K2[edit]

    On August 15, 2018, 70 people within the city of New Haven, Connecticut, started overdosing near Yale University campus.[15] By the end of the week, the total number of overdosed had risen to over 100 people needing transport to local emergency rooms. Three men were arrested, charged as drug dealers selling synthetic cannabis which contained AB-FUBINACA.[16][17][18] First responders concluded that the overdoses were caused by opiate adulterants, as victims responded to Narcan.[19] Almost all of the overdoses occurred on the New Haven Green, a large downtown park that is heavily traveled and very popular with the homeless population. There have been no deaths associated with these overdoses; however, several victims were in critical or life-threatening condition for a period of time.[20]

    See also[edit]

  • 5F-ADB
  • 5F-AMB
  • 5F-APINACA
  • AB-CHFUPYCA
  • AB-CHMINACA
  • AB-PINACA
  • ADB-CHMINACA
  • ADB-FUBINACA
  • ADBICA
  • AMB-FUBINACA
  • APICA
  • APINACA
  • Benzydamine
  • MDMB-CHMICA
  • MDMB-FUBINACA
  • NESS-040C5
  • PF-03550096
  • PX-3
  • References[edit]

    1. ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
  • ^ Pulver B, Fischmann S, Gallegos A, Christie R (March 2023). "EMCDDA framework and practical guidance for naming synthetic cannabinoids". Drug Testing and Analysis. 15 (3): 255–276. doi:10.1002/dta.3403. PMID 36346325.
  • ^ Banister SD, Moir M, Stuart J, Kevin RC, Wood KE, Longworth M, et al. (September 2015). "Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA". ACS Chemical Neuroscience. 6 (9): 1546–59. doi:10.1021/acschemneuro.5b00112. PMID 26134475.
  • ^ Hsin-Hung Chen M, Dip A, Ahmed M, Tan ML, Walterscheid JP, Sun H, et al. (April 2016). "Detection and Characterization of the Effect of AB-FUBINACA and Its Metabolites in a Rat Model". Journal of Cellular Biochemistry. 117 (4): 1033–43. doi:10.1002/jcb.25421. PMC 5063098. PMID 26517302.
  • ^ Vikingsson S, Gréen H, Brinkhagen L, Mukhtar S, Josefsson M (September 2016). "Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry". Drug Testing and Analysis. 8 (9): 950–6. doi:10.1002/dta.1896. PMID 26560240.
  • ^ WO 2009/106982, Buchler IP et al., "Indazole Derivatives" 
  • ^ Uchiyama N, Matsuda S, Wakana D, Kikura-Hanajiri R, Goda Y (January 2013). "New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products". Forensic Toxicology. 31 (1): 93–100. doi:10.1007/s11419-012-0171-4. S2CID 25242453.
  • ^ Trecki J, Gerona RR, Schwartz MD (July 2015). "Synthetic Cannabinoid-Related Illnesses and Deaths". The New England Journal of Medicine. 373 (2): 103–7. doi:10.1056/NEJMp1505328. PMID 26154784.
  • ^ Klavž J, Gorenjak M, Marinšek M (August 2016). "Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC". Forensic Science International. 265: 121–4. doi:10.1016/j.forsciint.2016.01.018. PMID 26890319.
  • ^ "Schedules of Controlled Substances: Temporary Placement of Four Synthetic Cannabinoids Into Schedule I". Drug Enforcement Administration, Department of Justice. 10 January 2014. Archived from the original on 28 February 2014. Retrieved 21 July 2015.
  • ^ "FINLEX ® - Säädökset alkuperäisinä: Valtioneuvoston asetus kuluttajamarkkinoilta… 698/2017".
  • ^ "Gesetz über den Verkehr mit Betäubungsmitteln (Betäubungsmittelgesetz - BtMG) Anlage II (zu § 1 Abs. 1) (verkehrsfähige, aber nicht verschreibungsfähige Betäubungsmittel)" (in German). Retrieved 22 June 2015.
  • ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 30 September 2015.
  • ^ "December 2019 – WHO: World Health Organization recommends 12 NPS for scheduling".
  • ^ Winston A (2018-08-15). "New Haven Overdoses Tied to Laced K2". The New York Times.
  • ^ "Police Arrest Third Suspect In New Haven Synthetic Marijuana Overdose Case". NPR. 17 August 2018. Retrieved 20 August 2018.
  • ^ "Dozens Overdose In Connecticut Park On Tainted Synthetic Marijuana". NPR. 16 August 2018. Retrieved 20 August 2018.
  • ^ "New Haven police make arrest after more than 100 K2 overdose calls". CNN. 18 August 2018. Retrieved 18 August 2018.
  • ^ Winston A (2018-08-15). "New Haven Overdoses Tied to Laced K2". The New York Times.
  • ^ "Police Arrest Third Suspect In New Haven Synthetic Marijuana Overdose Case". NPR. 17 August 2018. Retrieved 20 August 2018.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=AB-FUBINACA&oldid=1226684003"

    Categories: 
    Cannabinoids
    Designer drugs
    Fluoroarenes
    Indazolecarboxamides
    Hidden categories: 
    CS1 Brazilian Portuguese-language sources (pt-br)
    CS1 German-language sources (de)
    CS1 Chinese-language sources (zh)
    Articles with short description
    Short description matches Wikidata
    Drugs with non-standard legal status
    Articles without EBI source
    Chemical pages without DrugBank identifier
    Drugs missing an ATC code
    Articles containing unverified chemical infoboxes
     



    This page was last edited on 1 June 2024, at 06:16 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki